MAPT and supranuclear palsy, progressive, 1: Considering this structural heterogeneity between tauopathies, further studies using approaches such as cryo-EM and immuno-EM48 would be important to determine structural and morphological differences between tau seeds isolated from patients with AD, patients with PSP and PS19 mice.